RESILIENT: A Randomized, Double-Blind, Placebo-Controlled Study of Bimagrumab in Patients With Sporadic Inclusion Body Myositis

被引：0

作者：

Amato, Anthony A. ^{[1
]}

Badrising, Umesh ^{[2
]}

Benveniste, Olivier ^{[3
]}

Needham, Merrilee ^{[4
,5
]}

Chinoy, Hector ^{[6
]}

Wu, Min ^{[7
]}

Koumaras, Barbara ^{[7
]}

de Vera, Ana ^{[8
]}

Papanicolaou, Dimitris A. ^{[7
]}

Hanna, Michael G. ^{[9
]}

机构：

[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA

[2] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands

[3] Pierre & Marie Curie Univ, Pitie Salpetriere Hosp, Dept Internal Med, Paris, France

[4] Murdoch Univ, IIID, Fiona Stanley Hosp, Perth, WA, Australia

[5] Notre Dame Univ, Perth, WA, Australia

[6] Univ Manchester, Ctr Musculoskeletal Res, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England

[7] Novartis Pharmaceut, E Hanover, NJ USA

[8] Novartis Pharma AG, Basel, Switzerland

[9] UCL, Inst Neurol, MRC, Ctr Neuromuscular Dis, London, England

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1.111

引用

页数：3